GLP-1 Summer School: The Questions We’re Getting Asked All Summer Long

This week we're heading back to school, GLP-1 Summer School, to answer the questions we're getting asked every single day in clinic. A few years ago, hardly anyone had heard of medications like Ozempic, Wegovy, Mounjaro, and Zepbound. Now they're everywhere. Some people think they're a miracle. Others think they're dangerous. Most women are simply trying to sort through the noise and understand what is actually true. In this episode, we break down: • How GLP-1 medications actually work in the body • What realistic weight loss looks like with semaglutide and tirzepatide • Why these medications are about much more than weight loss • Whether you'll gain weight back after stopping and how to transition off successfully • The truth about muscle loss, hair loss, and "Ozempic face" • How GLP-1 therapy and hormone replacement therapy may work together • What patients should know about compounded medications • Why retatrutide is generating so much excitement for the future of obesity medicine We also discuss one of the biggest misconceptions surrounding GLP-1 therapy: the idea that the medication is the entire treatment plan. The medication may open the door, but long term success still depends on nutrition, muscle preservation, sleep, stress management, hormone health, and sustainable habits. This conversation is designed to help you understand the science, separate fact from fiction, and make sense of one of the fastest moving areas in medicine today. Share this with the friend who keeps texting you GLP-1 questions. #HumpDayHormones #GLP1 #Semaglutide #Tirzepatide #Ozempic #Wegovy #Zepbound #Mounjaro #MetabolicHealth #WeightLossMedicine #HormoneHealth #WomensHealth